|Articles|April 1, 1998

April 1998
Volume 4
Issue 4

Medicare HMOs: Who Joins and Who Leaves?

Author(s)Beth A. Virnig, PhD, MPH, Robert O. Morgan, PhD, Carolee A. DeVito, PhD, MPH

Download PDF: Medicare HMOs: Who Joins and Who Leaves?

Articles in this issue

over 28 years ago

Article

Cost of Migraine Management: A Pharmacoeconomic Overview

over 28 years ago

Article

A Program to Reduce Discharge Delays in a Neonatal Intensive Care Unit

over 28 years ago

Article

Attitudes and Behavioral Intentions Regarding Managed Care: A Comparison of Academic and Community Physicians

over 28 years ago

Article

Physician and Dietitian Prescribing of a Commercially Available Oral Nutritional Supplement

over 28 years ago

Article

A New Gatekeeper for Back Pain

over 28 years ago

Article

Influencing Physicians: The Three Critical Elements of a Successful Strategy

over 28 years ago

Article

Alzheimer's Disease: Clinical Features and Pharmacologic Management

over 28 years ago

Article

Changes in Benefit Payments and Health Insurance Premiums Among Firms Switching Health Insurance Carriers

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

Medicare HMOs: Who Joins and Who Leaves?

Articles in this issue

Related Content

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

Trending on AJMC

FAQs: FDA Lawsuit Challenges E-Cigarette Enforcement Policy, PMTA Guidance

Tec-Dara Closes Survival Gap in High-Risk MM: Rahul Banerjee, MD

Cognitive Rehabilitation Improves Functional Outcomes in Long COVID Brain Fog

PMOS Linked to 4-Fold Atherosclerotic Heart Disease Risk in 2.5 Million US Women

CAR T-Cell Therapy Shows Promise in Refractory Myasthenia Gravis, Evidence Still Limited